Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation Assay
(Adnkronos) – SAN DIEGO, May 11, 2023 /PRNewswire/ — “Today we are pleased to announce that Invivoscribe’s LeukoStrat® CDx FLT3 Mutation Assay has been approved by BSI (Netherlands) and the EMA as a
